Correlation Between Pmv Pharmaceuticals and Merus BV
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Merus BV, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Merus BV.
Diversification Opportunities for Pmv Pharmaceuticals and Merus BV
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pmv and Merus is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Merus BV go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Merus BV
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Merus BV. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.14 times less risky than Merus BV. The stock trades about -0.01 of its potential returns per unit of risk. The Merus BV is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 4,848 in Merus BV on August 27, 2024 and sell it today you would lose (299.00) from holding Merus BV or give up 6.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Merus BV
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Merus BV |
Pmv Pharmaceuticals and Merus BV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Merus BV
The main advantage of trading using opposite Pmv Pharmaceuticals and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |